2013

Hier vindt u een chronologisch overzicht van wetenschappelijke publicaties in 2013, gepubliceerd door de klinische onderzoeksgroepen die betrokken zijn bij ATHENA/SHM.

 

Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection
Lodi S, Fisher M, Phillips A, De Luca A, Ghosn J, Malyuta R, Zangerle R, Moreno S, Vanhems P, Boufassa F, Guiguet M, Porter K, for CASCADE Collaboration in EuroCoord
PLoS One. 2013 Nov 14;8(11):e78642. doi: 10.1371/journal.pone.0078642. eCollection 2013. Abstract

Associations between immune depression and cardiovascular events in HIV infection.
Sabin CA, Ryom L, De Wit S, Mocroft A, Phillips AN, Worm SW, Weber R, D'Arminio Monforte A, Reiss P, Kamara D, El-Sadr W, Pradier C, Dabis F, Law M,Lundgren J; D:A:D Study Group.
AIDS. 2013 Nov 13;27(17):2735-48. doi: 10.1097/01.aids.0000432457.91228.f3. Abstract

Gradually decreasing anal cancer incidence in the HIV+ population in the Netherlands after a decade of cART
Richel O, Van der Zee RP, Smit C, De Vries HJ, Prins JM.
Sex Health. 2013 Nov;10(6):586. doi: 10.1071/SHv10n6ab33. Abstract

Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study.
Worm SW, Bower M, Reiss P, Bonnet F, Law M, Fätkenheuer G, D Arminio Monforte A, Abrams DI, Grulich A, Fontas E, Kirk O, Furrer H, De Wit S, Phillips A, Lundgren JD, Sabin CA.
BMC Infect Dis. 2013 Oct 9;13(1):471. [Epub ahead of print] Abstract

The Presence of CXCR4-Using HIV-1 Prior to Start of Antiretroviral Therapy Is an Independent Predictor of Delayed Viral Suppression
Gijsbers EF, van Sighem A, Harskamp AM, Welkers MR, de Wolf F, Brinkman K, Prins JM, Schuitemaker H, van 't Wout AB, Kootstra NA.
PLoS One. 2013 Oct 1;8(10):e76255. Abstract

Changes in First-Line cART Regimens and Short-Term Clinical Outcome between 1996 and 2010 in The Netherlands.
Smit M, Smit C, Geerlings S, Gras L, Brinkman K, Hallett TB, de Wolf F; Athena Observational Cohort.
PLoS One. 2013 Sep 30;8(9):e76071. doi: 10.1371/journal.pone.0076071. Abstract

How effectively can HIV phylogenies be used to measure heritability?
G. Shirreff, S. Alizon, A. Cori, H.F. Günthard, O. Laeyendecker, A. van Sighem, D. Bezemer and C. Fraser
EMPH (2013) 2013 (1): 209-224. doi: 10.1093/emph/eot019. First published online: September 13, 2013 Abstract

Age biases in a large HIV and sexual behaviour-related internet survey among MSM
Marcus U, Hickson F, Weatherburn P, Schmidt AJ.
BMC Public Health. 2013 Sep 10;13(1):826. [Epub ahead of print] Abstract

Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).
Mocroft A, Lundgren JD, Sabin ML, Monforte AD, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, De Wit S, Fätkenheuer G, Furrer H, Johnson AM, Lazanas MK, Leport C, Moreno S, Obel N, Post FA, Reekie J, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Lozano I, Torti C, Warszawski J, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Kirk O; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord.
PLoS Med. 2013 Sep;10(9):e1001510. Epub 2013 Sep 3. Abstract

Missed Opportunities Among HIV-Positive Women to Control Viral Replication During Pregnancy and to Have a Vaginal Delivery
Aebi-Popp K, Mulcahy F, Glass TR, Rudin C, Martinez de Tejada B, Bertisch B, Fehr J, Grawe C, Scheibner K, Rickenbach M, Hoesli I, Thorne C; for the European Collaborative Study in EuroCoord and the Swiss Mother & Child HIV Cohort Study.
J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):58-65. Abstract

The effect of statin therapy on pneumonia in an HIV-infected population in the Netherlands
Janssen NE, van Lelyveld SF, Hoepelman AI, Gras L, Groenwold RH, Oosterheert JJ.
J Infect. 2013 Sep;67(3):238-41. doi: 10.1016/j.jinf.2013.04.011. Epub 2013 Apr 19. Abstract

Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe
Ryom L, Kirk O, Lundgren J, Reiss P, Pedersen C, De Wit S, Buzunova S, Gasiorowski J, Gatell J, Mocroft A; EuroSIDA in EuroCoord.
HIV Med. 2013 Sep;14(8):503-8. doi: 10.1111/hiv.12038. Epub 2013 Apr 16. Abstract

The effect of efavirenz versus nevirapine-containing regimens in the HIV-CAUSAL Collaboration: reply to Llibre and Podzamczer and additional results
Cain, Lauren E.; Hernán, Miguel A.; on behalf of the HIV-CAUSAL Collaboration.
AIDS. 2013 Aug 24;27(13):2169-2170. Abstract

Loss to follow-up and mortality rates in HIV-1 positive patients in Curaçao before and after the start of combined antiretroviral therapy
Hermanides H, Holman R, Gras L, Winkel C, Gerstenbluth I, de Wolf F, Duits A.
AIDS Res Hum Retroviruses. 2013 Aug 31. [Epub ahead of print] Abstract

The Incidence of AIDS-Defining Illnesses at a Current CD4 Count >=200 Cells/?L in the Post-Combination Antiretroviral Therapy Era
Mocroft A, Furrer HJ, Miro JM, Reiss P, Mussini C, Kirk O, Abgrall S, Ayayi S, Bartmeyer B, Braun D, Castagna A, d'Arminio Monforte A, Gazzard B, Gutierrez F, Hurtado I, Jansen K, Meyer L, Muñoz P, Obel N, Soler-Palacin P, Papadopoulos A, Raffi F, Ramos JT, Rockstroh JK, Salmon D, Torti C, Warszawski J, de Wit S, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Lundgren JD; for the Opportunistic Infections Working Group on behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD.
Clin Infect Dis. 2013 Aug 6. [Epub ahead of print] Abstract

Association between ALT level and the rate of cardio/cerebrovascular events in HIV-positive individuals: The D: A: D Study
Sabin CA, Ryom L, Kovari H, Kirk O, de Wit S, Law M, Reiss P, Dabis F, Pradier C, El-Sadr W, Monforte Ad, Kamara D, Phillips AN, Lundgren JD.
J Acquir Immune Defic Syndr. 2013 Aug 1;63(4):456-63. doi: 10.1097/QAI.0b013e318291cd29. Abstract

Does hepatitis C viremia or genotype predict the risk of mortality in individuals coinfected with HIV?
Rockstroh JK, Peters L, Grint D, Soriano V, Reiss P, Monforte Ad, Beniowski M, Losso MH, Kirk O, Kupfer B, Mocroft A; for EuroSIDA in EuroCoord.
J Hepatol. 2013 Aug;59(2):213-20. doi: 10.1016/j.jhep.2013.04.005. Epub 2013 Apr 11. Abstract

Natural History of HIV control since seroconversion
Madec Y, Boufassa F, Porter K, Prins M, Sabin C, Monforte AD, Amornkul P, Bartmeyer B, Sannes M, Venet A, Lambotte O, Meyer L; on behalf of the CASCADE Collaboration in Eurocoord.
AIDS. 2013 Aug 1. [Epub ahead of print] Abstract

Virologic and Immunologic Response to cART by HIV-1 Subtype in the CASCADE Collaboration
Touloumi G, Pantazis N, Chaix ML, Bucher HC, Zangerle R, Kran AM, Thiebaut R, Masquelier B, Kucherer C, Monforte Ad, Meyer L, Porter K; for CASCADE Collaboration in EuroCoord.
PLoS One. 2013 Jul 30;8(7):e71174. doi: 10.1371/journal.pone.0071174. Print 2013. Abstract

Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy
Grint D, Peters L, Reekie J, Soriano V, Kirk O, Knysz B, Suetnov O, Lazzarin A, Ledergerber B, Rockstroh J, Mocroft A; EuroSIDA in EuroCoord.
HIV Med. 2013 Jul;14(6):370-8. doi: 10.1111/hiv.12033. Epub 2013 Mar 27. Abstract

Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996-2012.
Cohen S, Smit C, van Rossum AM, Fraaij PL, Wolfs TF, Geelen SP, Schölvinck EH, Warris A, Scherpbier HJ, Pajkrt D; on behalf of the Dutch paediatric HIV study group.
AIDS. 2013 Jul 9. [Epub ahead of print] Abstract

Performance of parametric survival models under non-random interval censoring: a simulation study
Pantazis N, Kenward MG, Touloumi G, on behalf of CASCADE Collaboration in EuroCoord
Computational Statistics & Data Analysis, Volume 63, July 2013; 16-30. DOI: 10.1016/j.csda.2013.01.014 Abstract

Sexually transmitted infections, including HIV, in the Netherlands in 2012
Soetens LC, Koedijk FDH, van den Broek IVF, Vriend HJ, Op de Coul ELM, van Aar F, van Sighem AI, Stirbu-Wagner I, van Benthem BHB.
RIVM report number: 150002003/2013; ISBN 978-90-6960-264-6 Artikel

Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients.
Peters L, Mocroft A, Soriano V, Rockstroh J, Rauch A, Karlsson A, Knysz B, Pradier C, Zilmer K, Lundgren JD; for EuroSIDA in EuroCoord.
PLoS One. 2013 May 27;8(5):e64283. doi: 10.1371/journal.pone.0064283. Print 2013. Abstract

Has the Rate of CD4 Cell Count Decline before Initiation of Antiretroviral Therapy Changed over the Course of the Dutch HIV Epidemic among MSM?
Gras L, Geskus RB, Jurriaans S, Bakker M, van Sighem A, Bezemer D, Fraser C, Prins JM, Berkhout B; Frank de Wolf1,4 for the ATHENA national observational cohort.
PLoS One. 2013 May 27;8(5):e64437. doi: 10.1371/journal.pone.0064437. Print 2013. Abstract

Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis
Antiretroviral Therapy Cohort Collaboration (ART-CC), Shepherd BS, Jenkins CA, Parrish DD, Glass TR, Cescon A, Masabeu A, Chene G, de Wolf F, Crane HM, Jarrin I, Gill J, del Amo J, Abgrall S, Khaykin P, Lehmann C, Ingle SM, May MT, Sterne JA, Sterling TR.
AIDS. 2013 May 15;27(8):1321-9. doi: 10.1097/QAD.0b013e32835faa95. Abstract

Severe bacterial non-AIDS infections in HIV-positive persons: incidence rates and risk factors
Søgaard OS, Reekie J, Ristola M, Jevtovic D, Karpov I, Beniowski M, Servitskiy S, Domingo P, Reiss P, Mocroft A, Kirk O.
J Infect. 2013 May;66(5):439-46. doi: 10.1016/j.jinf.2012.12.012. Epub 2013 Jan 24. Abstract

Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands; host or environmental factors?
Schoffelen AF, van Lelyveld SF, Barth RE, Gras L, de Wolf F, Netea MG, Hoepelman AI.
AIDS. 2013 Apr 24;27(7):1179-84. Epub 2012 Dec 31. Abstract

Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants
Chiappini E, Galli L, Giaquinto C, Ene L, Goetghebuer T, Judd A, Lisi C, Malyuta R, Noguera-Julian A, Ramos JT, Rojo-Conejo P, Rudin C, Tookey P, de Martino M, Thorne C; European Pregnancy and Paediatric HIV Cohort Collaboration study group in EuroCoord.
AIDS. 2013 Mar 27;27(6):991-1000. doi: 10.1097/QAD.0b013e32835cffb1. Abstract

CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use
Mocroft A, Phillips AN, Gatell J, Horban A, Ledergerber B, Zilmer K, Jevtovic D, Maltez F, Podlekareva D, Lundgren JD; EuroSIDA study in EuroCOORD.
AIDS. 2013 Mar 27;27(6):907-18. doi: 10.1097/QAD.0b013e32835cb766. Abstract

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.
Rotger M, Glass TR, Junier T, Lundgren J, Neaton JD, Poloni ES, van 't Wout AB, Lubomirov R, Colombo S, Martinez R, Rauch A, Günthard HF, Neuhaus J, Wentworth D, van Manen D, Gras LA, Schuitemaker H, Albini L, Torti C, Jacobson LP, Li X, Kingsley LA, Carli F, Guaraldi G, Ford ES, Sereti I, Hadigan C, Martinez E, Arnedo M, Egaña-Gorroño L, Gatell JM, Law M, Bendall C, Petoumenos K, Rockstroh J, Wasmuth JC, Kabamba K, Delforge M, De Wit S, Berger F, Mauss S, de Paz Sierra M, Losso M, Belloso WH, Leyes M, Campins A, Mondi A, De Luca A, Bernardino I, Barriuso-Iglesias M, Torrecilla-Rodriguez A, Gonzalez-Garcia J, Arribas JR, Fanti I, Gel S, Puig J, Negredo E, Gutierrez M, Domingo P, Fischer J, Fätkenheuer G, Alonso-Villaverde C, Macken A, Woo J, McGinty T, Mallon P, Mangili A, Skinner S, Wanke CA, Reiss P, Weber R, Bucher HC, Fellay J, Telenti A, Tarr PE; MAGNIFICENT Consortium; INSIGHT; Swiss HIV Cohort Study.
Clin Infect Dis. 2013 Jul;57(1):112-21. doi: 10.1093/cid/cit196. Epub 2013 Mar 26. Abstract

Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings.
Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers RL, Alvarez-Uria G, Streinu-Cercel A, Ene L, Wensing AM, Dewolf F, Nelson M, Montaner JS, Lane HC, Larder BA; on behalf of the RDI study group.
J Antimicrob Chemother. 2013 Jun;68(6):1406-14. Epub 2013 Mar 13. Abstract

Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts
Touloumi G, Pantazis N, Pillay D, Paraskevis D, Chaix ML, Bucher HC, Kücherer C, Zangerle R, Kran AM, Porter K; CASCADE collaboration in EuroCoord.
Clin Infect Dis. 2013 Mar;56(6):888-97. doi: 10.1093/cid/cis1000. Epub 2012 Dec 7. Abstract

Risk of tuberculosis following HIV seroconversion in high-income countries.
Lodi S, del Amo J, d'Arminio Monforte A, Abgrall S, Sabin C, Morrison C, Furrer H, Muga R, Porter K, Girardi E; CASCADE collaboration in EuroCoord.
Thorax. 2013 Mar;68(3):207-13. doi: 10.1136/thoraxjnl-2012-201740. Epub 2012 Oct 31. Abstract

Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study.
Kovari H, Sabin CA, Ledergerber B, Ryom L, Worm SW, Smith C, Phillips A, Reiss P, Fontas E, Petoumenos K, De Wit S, Morlat P, Lundgren JD, Weber R.
Clin Infect Dis. 2013 Mar;56(6):870-9. doi: 10.1093/cid/cis919. Epub 2012 Oct 22. Abstract

Influence of geographical origin and ethnicity on mortality in patients on antiretroviral therapy in Canada, Europe and the United States.
The Antiretroviral Therapy Cohort Collaboration (ART-CC).
Clin Infect Dis. 2013 Jun;56(12):1800-9. Epub 2013 Mar 1. Abstract

Insurability of HIV positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies.
Kaulich-Bartz J, Dam W, May MT, Lederberger B, Widmer U, Phillips AN, Grabar S, Mocroft A, Vilaro J, van Sighem A, Moreno S, Dabis F, Monforte AD, Teira R, Ingle SM, Sterne JA; Writing committee for the Antiretroviral Cohort Collaboration.
AIDS. 2013 Feb 25. [Epub ahead of print] Abstract

High incidence of intermittent care in HIV-1-infected patients in Curaçao before and after starting cART.
Hermanides HS, Holman R, Gras L, Winkel CN, Gerstenbluth I, de Wolf F, Duits AJ.
AIDS Care. 2013 Feb 21. [Epub ahead of print] Abstract

An internationally generalizable risk index for mortality after one year of antiretroviral therapy.
Tate JP, Justice AC, Hughes MD, Bonnet F, Reiss P, Mocroft A, Nattermann J, Lampe FC, Bucher HC, Sterling TR, Crane HM, Kitahata MM, May M, Sterne JA.
AIDS. 2013 Feb 20;27(4):563-72. doi: 10.1097/QAD.0b013e32835b8c7f. Abstract

Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.
Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, Ross M, Fux CA, Morlat P, Moranne O, Smith C, Lundgren JD; D:A:D Study Group.
J Infect Dis. 2013 May 1;207(9):1359-69. doi: 10.1093/infdis/jit043. Epub 2013 Feb 4. Abstract

Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events
Monforte Ad, Reiss P, Ryom L, El-Sadr W, Dabis F, De Wit S, Worm SW, Law MG, Weber R, Kirk O, Pradier C, Phillips AN, Lundgren JD, Sabin CA.
AIDS. 2013 Jan 28;27(3):407-15. doi: 10.1097/QAD.0b013e32835b2ef1. Abstract

HIV-infected mental health patients: characteristics and comparison with HIV-infected patients from the general population and non-infected mental health patients.
Schadé A, van Grootheest G, Smit JH.
BMC Psychiatry. 2013 Jan 23;13:35. doi: 10.1186/1471-244X-13-35. Abstract

Prolonged decrease of CD4+ T lymphocytes in HIV-1 infected patients after radiotherapy for a solid tumor.
Sankatsing SU, Hillebregt MM, Gras L, Brinkman K, van der Ende M, de Wolf F, Stalpers LJ, Prins JM.
J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):546-9. Epub Jan 10. Abstract

Predictors of CD4+ T-Cell Counts of HIV Type 1-Infected Persons After Virologic Failure of All 3 Original Antiretroviral Drug Classes.
The Pursuing Later Treatment Option II (PLATO II) Project Team of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE).
J Infect Dis. 2013 Mar 1;207(5):759-67. Epub 2012 Dec 7. Abstract

Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997
van der Helm J, Geskus R, Sabin C, Meyer L, Del Amo J, Chêne G, Dorrucci M, Muga R, Porter K, Prins M; CASCADE Collaboration in EuroCoord.
Gastroenterology. 2013 Apr;144(4):751-760.e2. Epub 2012 Dec 22. Abstract

Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and N.America 2002-2009
Abgrall S; The Antiretroviral Therapy Cohort Collaboration (ART-CC)
AIDS. 2013 Mar 13;27(50:803-13. Epub AIDS. 2012 Nov 28. Abstract

 
 

Stichting HIV Monitoring

Stichting HIV Monitoring (SHM) levert een belangrijke en noodzakelijke bijdrage aan de zorg voor mensen met hiv in Nederland. Door middel van het verzamelen en bewerken van gecodeerde data van hiv-positieve personen uit het hele land draagt ons monitor-onderzoek structureel bij aan de kennis over hiv en stelt het behandelend artsen in staat om de zorg voor hun patiënten continu te verbeteren. Ons jaarlijkse Monitoring Report geeft waardevolle input voor het ontwikkelen van hiv-zorg en preventiebeleid in Nederland en binnen de Europese Unie.

Bezoekadres

Nicolaes Tulphuis
Tafelbergweg 51
1105 BD Amsterdam

Postadres

Academisch Medisch Centrum
Universiteit van Amsterdam
Meibergdreef 9 1105 AZ Amsterdam

© Stichting HIV Monitoring  | Disclaimer  | Colofon